Aammaad Shams - 01 Aug 2022 Form 4 Insider Report for Evolent Health, Inc. (EVH)

Role
Chief Accounting Officer
Signature
/s/ Jonathan Weinberg, Attorney-in-fact
Issuer symbol
EVH
Transactions as of
01 Aug 2022
Net transactions value
$0
Form type
4
Filing time
04 Aug 2022, 17:50:58 UTC
Previous filing
03 Mar 2022
Next filing
03 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EVH Class A Common Stock Award $0 +17,247 +88% $0.000000 36,884 01 Aug 2022 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units granted to Mr. Shams pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.
F2 Securities vest at a rate of 34% on August 1, 2023, and 33% on August 1, 2024, and August 1, 2025.
F3 Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.